Ozempic May Lower Dementia Risk in People With Type 2 Diabetes, Study Finds

United States News News

Ozempic May Lower Dementia Risk in People With Type 2 Diabetes, Study Finds
United States Latest News,United States Headlines
  • 📰 PreventionMag
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

Looking for ways to improve your memory and focus? It could be as simple as chatting with a friend or picking up sudoku.

Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline in a new study. The study only focused on patients with type 2 diabetes.Doctors say there may be something to this.The last year has seen an explosion of research about the perks of taking Ozempic, a type 2 diabetes medication that some use off-label for weight loss.

Meaning, it’s not clear how taking semaglutide might impact the risk of cognitive decline in people without type 2 diabetes.Also, this study didn’t prove that semaglutide actually lowered the risk of developing cognitive decline—it merely found a link between people who took the medication and those who were less likely to develop cognitive issues that could include dementia.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

PreventionMag /  🏆 141. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine useHealthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine useNew study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes…
Read more »

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine useHealthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine useNew study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes…
Read more »

Ozempic and similar drugs may lower cancer risks, study findsOzempic and similar drugs may lower cancer risks, study findsPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »

Hormone Therapy for Breast Cancer May Lower Dementia RiskHormone Therapy for Breast Cancer May Lower Dementia RiskHormone therapy for breast cancer might reduce a woman’s later risk of dementia and Alzheimer’s disease, a new study finds.
Read more »

Ozempic Linked to Significantly Reduced Dementia RiskOzempic Linked to Significantly Reduced Dementia RiskScience and Technology News and Videos
Read more »

Ozempic could lower risk of cognitive problems, new study showsOzempic could lower risk of cognitive problems, new study showsPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »



Render Time: 2025-02-23 03:03:58